Prescribing information

 

Heart to Heart is a new podcast series designed for Heart Failure Specialist Nurses. In each episode, we speak to leading Nurses about tackling challenges and invite them to share insights into developments in the field of heart failure.

The Heart to Heart podcast aims to present information about topics such as treatments for chronic HFrEF, guideline updates and the latest research. By presenting this in an easily accessible way, we hope the podcast becomes a valuable resource and creates a supportive community for discussion and debate.

Meet our host

Meet the ‘Heart to Heart’ podcast host Paul Marriott, Professional Relations Manager (PRM) for Novartis’ cardiovascular portfolio.

Working with national organisations and individuals across the UK, Paul has a passion for raising the awareness of Heart Failure and best practice sharing across disease areas.

Throughout this series Paul will be meeting Heart Failure Specialist Nurses who are at the centre of patient care to hear more about how they are overcoming local challenges and finding innovative solutions to ensure all patients receive optimal, individualised treatment in a timely manner.

 

 

 

 

In this episode, we speak to Carys Barton about the unique role of the Heart Failure Specialist Nurse. She discusses how a holistic approach to treatment and building relationships with patients and their families can help people live better for longer.

Carys also shares her views on the importance of mentorship and how utilising the competency framework can support learning, funding and access to resources.

 

 

 

In this episode, Diane Taylor from the Wirral discusses why local guidelines have been changed to recognise HFSNs as specialists and to enable them to initiate Entresto. As well as discussing how this was possible, Diane shares her experience of the impact of Entresto on patient outcomes, and why it has led to earlier initiation for eligible symptomatic chronic HFrEF patients.

 

 

 

HFSN Pearl Lesson shares her vast experience across multiple settings on the role that primary care, secondary care and community services play in the effective management of chronic HFrEF. She discusses how this is evolving and why early identification of chronic heart failure is vital. During this episode, Pearl highlights the main symptoms that all clinicians should look out for, shares her experience with Entresto and discusses its impact on patient symptoms.

 

Click here to register for notification of new podcast episodes and portal updates

Indications: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1

HCP, healthcare professional; HFrEF, heart failure with reduced ejection fraction; HFSN, Heart Failure Specialist Nurse.

Reference

  1. Entresto Summary of Product Characteristics, 2021.
Rate this content: 
Average: 5 (4 votes)
UK | December 2021 | 177653
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]